Antigen‐independent activation of the first component of complement C1 by chemically crosslinked rabbit IgG‐oligomers

No abstract is available for this paper.

• Publication year

  1980

• Venue

  FEBS Letters

• Publication date

  1980-04-07

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0014-5793(80)80168-2PMID 7371851
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interaction of 125I‐labelled complement subcomponents C r and C s with protease inhibitors in plasma

  1979cited by this paper
• A unique enzyme — protein substrate modifier reaction: Plasmin/streptokinase interaction

  1979cited by this paper
• The transition of bovine trypsinogen to a trypsin-like state upon strong ligand binding. II. The binding of the pancreatic trypsin inhibitor and of isoleucine-valine and of sequentially related peptides to trypsinogen and to p-guanidinobenzoate-trypsinogen.

  1979cited by this paper
• The biochemistry of complement.

  1978cited by this paper
• The effect of antigen on antibodies: recent studies.

  1978cited by this paper
• Activation of the first component of human complement (C1) by antibody-antigen aggregates.

  1978cited by this paper
• Independence of the binding of domain‐specific ligands to Fab and Fc suggests that antigen‐induced effects in IgG antibodies are not allosteric

  1978cited by this paper
• Occurrence of idiotypically identical antibodies in the sera of two outbred rabbits hyperimmunized with type II pneumococcal vaccine.

  1978cited by this paper
• Biochemistry of complement

  1977cited by this paper
• Reconstitution of C1 in native proenzyme form and its use in a quantitative C1 activation test.

  1977cited by this paper
• Ultracentifuge studies of the binding of IgG of different subclasses to the Clq subunit of the first component of complement.

  1976cited by this paper
• The unactivated form of the first component of human complement, C1.

  1976cited by this paper
• Ultracentifuge studies of the binding of IgG of different subclasses to the Clq subunit of the first component of complement.

  1976cited by this paper
• C1 fixation and classical complement pathway activation by a fragment of the Cmu4 domain of IgM

  1975cited by this paper
• Complement.

  1975cited by this paper
• Antigen-induced conformational changes in antibodies and their Fab fragments studied by circular polarization of fluorescence.

  1975cited by this paper
• Effect of antigen binding on the properties of antibody.

  1974cited by this paper
• Studies on the complement-binding site of rabbit immunoglobulin G-11. The reaction of rabbit IgG and its fragments with Clq.

  1974cited by this paper
• A simple method for the isolation of the subcomponents of the first component of complement by affinity chromatography.

  1974cited by this paper
• A fragment corresponding to the CH2 region of immunoglobulin G (IgG) with complement fixing activity

  1972cited by this paper
• Anticomplementary activity of γG-immunoglobulins and of their subunits

  1970cited by this paper
• Anticomplementary activity of gamma G-immunoglobulins and of their subunits.

  1970cited by this paper

• Complement activation by IgG subclasses is governed by their ability to oligomerize upon antigen binding

  2024cites this paper
• Unraveling the Macromolecular Pathways of IgG Oligomerization and Complement Activation on Antigenic Surfaces.

  2019cites this paper
• IgG cooperativity – Is there allostery? Implications for antibody functions and therapeutic antibody development

  2017cites this paper
• Potent Human Immunodeficiency Virus-Neutralizing and Complement Lysis Activities of Antibodies Are Not Obligatorily Linked

  2008cites this paper
• The effect of adaptive and innate immune response on HIV-1 entry and replication

  2007cites this paper
• Initiation of complement activation

  2005cites this paper
• The first component of human complement (C1): Activation and control

  2004cites this paper
• The Crystal Structure of a Five-Stranded Coiled Coil in COMP: A Prototype Ion Channel?

  1996cites this paper
• Chapter 18 – Complement as an Effector Mechanism of Antibodies in Host Defense

  1994cites this paper
• The structure of immunoglobulins and their interaction with complement

  1993cites this paper
• Defined chemically cross-linked oligomers of human C-reactive protein: characterization and reactivity with the complement system.

  1991cites this paper
• Binding of the human complement subcomponent C1q to hybrid mouse monoclonal antibodies.

  1991cites this paper
• Use of intravenous gammaglobulin as an immune replacement and an immune suppressant.

  1989cites this paper
• Electron microscopy and other physical methods for the characterization of extracellular matrix components: laminin, fibronectin, collagen IV, collagen VI, and proteoglycans.

  1987cites this paper
• Activation of the first component of complement.

  1987cites this paper
• Kinetics of C1 activation by a monoclonal anti-C1q antibody and its (Fab)2 fragments.

  1987cites this paper
• Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.

  1986cites this paper
• The modulation of immune complex aggregation by classical pathway-mediated reactions.

  1985cites this paper
• Activation of the human classical complement pathway by a mouse monoclonal hybrid IgG1-2a monovalent anti-TNP antibody bound to TNP-conjugated cells.

  1985cites this paper
• Activation of C1 by monoclonal antibodies directed against C1q.

  1985cites this paper
• The classical complement pathway: activation and regulation of the first complement component.

  1985cites this paper
• Immunoglobulin G: functional sites.

  1985cites this paper
• Binding and Activation of the First Complement Component by Soluble Immune Complexes: Effect of Complex Size and Composition

  1984cites this paper
• Binding of complement subcomponent C1q to mouse IgG1, IgG2a and IgG2b: a novel C1q binding assay.

  1984cites this paper
• The C1q receptor site on human immunoglobulin G.

  1984cites this paper
• [Binding and activation of the first component of human complement on artificial matrices].

  1984cites this paper
• Structural studies on DNP binding antibodies

  1983cites this paper
• C1- inactivator: its efficiency as a regulator of classical complement pathway activation by soluble IgG aggregates.

  1983cites this paper
• The role of non-immune IgG in controlling IgG-mediated effector functions.

  1983cites this paper
• Structural basis of antibody function.

  1983cites this paper
• Biochemical Specificity of Human Complement Component C1q

  1983cites this paper
• The Role of IgE and Its Receptor in Mediating Secretion

  1983cites this paper
• Dissociation of C1 and concentration dependence of its activation kinetics.

  1982cites this paper
• Kinetics of activation of the first component of complement (C1) by IgG oligomers.

  1982cites this paper
• Influence of aggregate size on the binding and activation of the first component of human complement by soluble IgG aggregates.

  1982cites this paper
• C1q binding to antibody-coated cells: predictions from a simple multivalent binding model.

  1981cites this paper
• Antigen‐independent binding of IgG dimers to C1 q as studied by sedimentation equilibrium, complement fixation and electron microscopy

  1980cites this paper
• Assembly of subcomponents C1r and C1s of first component of complement: electron microscopic and ultracentrifugal studies.

  1980cites this paper